Status:
COMPLETED
Milrinone During Living Donor Hepatectomy
Lead Sponsor:
Seoul National University Hospital
Conditions:
Hepatectomy
Eligibility:
All Genders
19-55 years
Phase:
NA
Brief Summary
Maintaining a low central venous pressure during living donor hepatectomy is routine practice. The investigators tried to test the hypothesis that using milrinone to maintain a low central venous pres...
Eligibility Criteria
Inclusion
- Living liver donors
Exclusion
- Donors with concurrent cardiac, pulmonary, and urologic disease
- Hepatectomy performed laparoscopically
Key Trial Info
Start Date :
January 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2008
Estimated Enrollment :
38 Patients enrolled
Trial Details
Trial ID
NCT00966745
Start Date
January 1 2008
End Date
December 1 2008
Last Update
August 27 2009
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Seoul National University Hospital
Seoul, South Korea, 110-744